Markus Weigand, MD

Department of Anaesthesiology, Heidelberg University Hospital, Heidelberg, Germany, Germany

Disclosure(s): Bbraun: Speakers fee/ad boards fee; Biotest: Speakers fee/ad boards fee; Eumedica: Speakers fee/ad boards fee; Gilead: Speakers fee/ad boards fee; MSD: Speakers fee/ad boards fee; Pfizer: Speakers fee/ad boards fee; Shionogi: Speakers fee/ad boards fee; SOBI: Speakers fee/ad boards fee

Poster(s):

• 1142 - Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET